Basics |
AbCellera Biologics Inc.
|
IPO Date: |
December 11, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.18B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.39 | 3.08%
|
Avg Daily Range (30 D): |
$0.19 | 5.21%
|
Avg Daily Range (90 D): |
$0.11 | 3.96%
|
Institutional Daily Volume |
Avg Daily Volume: |
2.14M |
Avg Daily Volume (30 D): |
7.83M |
Avg Daily Volume (90 D): |
5.23M |
Trade Size |
Avg Trade Size (Sh.): |
156 |
Avg Trade Size (Sh.) (30 D): |
297 |
Avg Trade Size (Sh.) (90 D): |
330 |
Institutional Trades |
Total Inst.Trades: |
1,174 |
Avg Inst. Trade: |
$1.88M |
Avg Inst. Trade (30 D): |
$.81M |
Avg Inst. Trade (90 D): |
$1.13M |
Avg Inst. Trade Volume: |
.16M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.09M |
Avg Closing Trade (30 D): |
$.83M |
Avg Closing Trade (90 D): |
$.79M |
Avg Closing Volume: |
203.03K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q3 2024 |
Basic EPS
|
|
$-.15
|
$-.17
|
Diluted EPS
|
|
$-.15
|
$-.17
|
Revenue
|
$
|
$ 4.24M
|
$ 6.51M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$
|
$ -45.62M
|
$ -51.11M
|
Operating Income / Loss
|
$
|
$ -62.66M
|
$ -93.66M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$
|
$ 2.94M
|
$ -21.67M
|
PE Ratio
|
|
|
|
|
|
|